Biomarkers of oxidative stress, inflammation, and genotoxicity to assess exposure to micro- and nanoplastics. A literature review.

Biomarkers Cytokines Genotoxicity Inflammation Microplastics Nanoplastics Oxidative stress

Journal

Ecotoxicology and environmental safety
ISSN: 1090-2414
Titre abrégé: Ecotoxicol Environ Saf
Pays: Netherlands
ID NLM: 7805381

Informations de publication

Date de publication:
15 Nov 2023
Historique:
received: 30 06 2023
revised: 24 10 2023
accepted: 27 10 2023
medline: 21 11 2023
pubmed: 6 11 2023
entrez: 3 11 2023
Statut: ppublish

Résumé

The increased awareness about possible health effects arising from micro- and nanoplastics (MNPs) pollution is driving a huge amount of studies. Many international efforts are in place to better understand and characterize the hazard of MNPs present in the environment. The literature search was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology in two different databases (PubMed and Embase). The selection of articles was carried out blind, screening titles and abstracts according to inclusion and exclusion criteria. In general, these studies rely on the methodology already in use for assessing hazard from nanomaterials and particles of concern. However, only a limited number of studies have so far directly measured human exposure to MNPs and examined the relationship between such exposure and its impact on human health. This review aims to provide an overview of the current state of research on biomarkers of oxidative stress, inflammation, and genotoxicity that have been explored in relation to MNPs exposure, using human, cellular, animal, and plant models. Both in-vitro and in-vivo models suggest an increased level of oxidative stress and inflammation as the main mechanism of action (MOA) leading to adverse effects such as chronic inflammation, immunotoxicity and genotoxicity. With the identification of such biological endpoints, representing critical key initiating events (KIEs) towards adaptive or adverse outcomes, it is possible to identify a panel of surrogate biomarkers to be applied and validated especially in occupational settings, where higher levels of exposure may occur.

Identifiants

pubmed: 37922781
pii: S0147-6513(23)01149-1
doi: 10.1016/j.ecoenv.2023.115645
pii:
doi:

Substances chimiques

Microplastics 0
Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

115645

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Marco Panizzolo (M)

Department of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy.

Vitor Hugo Martins (VH)

Department of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy.

Federica Ghelli (F)

Department of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy.

Giulia Squillacioti (G)

Department of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy.

Valeria Bellisario (V)

Department of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy.

Giacomo Garzaro (G)

Department of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy.

Davide Bosio (D)

Unit of Occupational Medicine, A.O.U Città della Salute e della Scienza di Torino, Turin, Italy.

Nicoletta Colombi (N)

Federated Library of Medicine "F. Rossi", University of Turin, 10126 Turin, Italy.

Roberto Bono (R)

Department of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy. Electronic address: roberto.bono@unito.it.

Enrico Bergamaschi (E)

Department of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH